Mucosal and systemic adjuvant activity of alphavirus replicon particles. - sprookjes - yvandenbroek - TriplyDB

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

http://www.wikidata.org/entity/Q34410789

about

Vaccines for gonorrhea: can we rise to the challenge?A novel self-replicating chimeric lentivirus-like particle Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaques Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish Advanced vaccine candidates for Lassa fever Prime-boost approaches to tuberculosis vaccine development Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 Vaccines for Venezuelan equine encephalitis Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.Identification of cross-reactive norovirus CD4+ T cell epitopes A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.Enteric reovirus infection stimulates peanut-specific IgG2a responses in a mouse food allergy model.An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice Virus-vectored influenza virus vaccines.Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.Lipopolysaccharide inhibits Sindbis virus-induced IP-10 release in human peripheral blood mononuclear cells.Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.Next-generation dengue vaccines: novel strategies currently under development.A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge.Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node.Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

P2860

Q21131153-90AB9F58-C398-4BBE-A085-B8B318A2CE63 Q24611993-080582FD-9AAB-4019-A065-03F414D2E467 Q24633851-2E981BAD-A1AB-48F6-8F95-7BAA189B23B1 Q24634730-D67EE59E-28BA-4DD6-A4EA-82A747513FC9 Q24657762-52D976E3-9018-404B-86F6-038B8E2F55A6 Q26777943-3CB02BD4-DC1D-40CB-9087-6FF123FCCC4A Q26823627-272580B3-19A4-46EF-A70B-132E720F3418 Q27024526-B8E1869C-8F5D-418C-90FB-C24229A7D71F Q27481032-428DBC2B-8748-4691-9AF1-A25D82F63C0D Q27481478-0659C4AA-CDBB-41D2-A080-EF546FDCA434 Q27485003-E491BA39-9084-4723-9D05-6F965D4C1357 Q27486582-FEDE1E3B-9729-4DD5-B4BA-B5B2AA4ABEE5 Q27490196-0FACD65D-1BB4-4F42-9600-17E6C5D1A1B5 Q28752489-3A1358D1-601B-497D-8747-EF5D3EA25A51 Q33316163-647962A1-E2B1-4DDE-A588-C62F9FEA86FB Q33351971-96E126CE-5872-4A76-AAA3-F2AA496D2FEF Q33392684-01B6317B-590A-42A6-BF9D-D0EB118C6E48 Q33614545-F31AB308-98D4-4057-8655-29D820D741EE Q33769306-0E3779EA-8BDE-4930-AC83-8F471ECDF3EE Q33972018-922AF1A2-0346-405B-B73F-99160041157C Q34014468-FB42BFE9-B8BF-4613-8335-991E5BBF4DEE Q34059308-EC827D7C-5726-4264-9E55-8237116BA7F9 Q34102268-81270EC2-F2E2-4DC5-A2D4-E82724CCD6E1 Q34457808-23011999-8226-4288-AD2C-717A13FE7EE6 Q34717846-CB86A9AB-F753-40FE-BA08-C45EAB84A03D Q34778787-90747FD3-AE0B-41E1-88EB-D40DA6417BDE Q35027794-D7CF7ADD-298F-4D0D-BDC0-9641068A69FF Q35034240-10BBDEA7-53AB-4097-8519-5390D166EAEF Q35076889-C83297C5-47A5-43CC-9245-F59E4026C388 Q35491639-3645041B-9734-42B5-AA19-6E9411F35989 Q35531454-5878F51C-68E7-41E5-977F-C75397DB6671 Q35758746-9BC8D53B-ABA8-4F3F-87FD-605451E21009 Q36114605-30375D84-9C16-479C-8C60-42E7CE26DA30 Q36315159-8EF1C666-3104-49AD-934A-4BCC6DBDD00A Q36458651-46D177DD-0522-4B07-90C0-27FE7304FA5A Q36488876-2B9457BB-DA64-449B-A882-7AB4D283EC20 Q36605148-A03249F9-E2CC-4D5E-87CC-1B58AE36FB67 Q36677419-DFFFF9AA-459A-4017-AD2E-27A4C173A809 Q36702201-9A494EC3-DF88-4F6C-92CF-99BD0D036ED0 Q36716920-E4D42881-E52E-46E3-AF4F-BBFE2DBA2F74

P2860

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

http://www.wikidata.org/entity/Q34410789

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@ast

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@en

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@nl

type

label

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@ast

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@en

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@nl

prefLabel

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@ast

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@en

Mucosal and systemic adjuvant activity of alphavirus replicon particles.

@nl

P1433

Q34410789-FA398BA1-7970-4E78-A296-8DD55227D97C

P1476

Q34410789-09B1D448-9927-426C-8C74-C6B106422F96

P2093

Q34410789-04629EDE-FA69-4F8D-B39E-EDCFBD303BAB

Q34410789-070D1D24-16C6-4C73-8A36-47DCC4D2F44F

Q34410789-515BB5B7-5E87-4604-93FA-19B3B38EA92A

Q34410789-9A0670E5-F95C-4A09-A348-02809F138563

Q34410789-BA0897F4-A49D-4520-9F3D-ED26287EE122

Q34410789-DD05B187-C340-4A10-AFBC-A50CF4F205CD

Q34410789-F7B5A19F-369C-4A25-B181-FEE40B732C22

P2860

Q34410789-0018A30B-E8B4-420B-8FF9-48EB464A53B3

Q34410789-00F4F17D-CBFE-4100-9829-E4E306C2311D

Q34410789-0CAE5282-BF76-417A-A615-0DDAD91984D2

Q34410789-0F61C60D-7A3D-4A14-9E96-AA4FD888584E

Q34410789-14D80111-2802-4A19-BF7D-9E8135C11753

Q34410789-16D3DB19-EE38-492F-ADD8-6A9845164731

Q34410789-17C3C961-4E6D-47BF-9B5E-2B2F661009C9

Q34410789-22554D41-4CE2-4A40-B37B-86712406091B

Q34410789-251C2503-DA32-4CFF-8969-E36B8600FBCD

Q34410789-38FEDF21-4DD1-4617-B624-D964A6BEAFBF

P304

Q34410789-B9351895-6E1F-4E32-A565-BD89A6F99371

P31

Q34410789-52F7E6BC-0D71-4B71-AFC1-7582644F2616

P356

Q34410789-7DC68C06-2B78-4427-BE28-A02C261C2114

P407

Q34410789-A666B21E-35CC-4AE0-A72D-F4A5AF34F5E8

P433

Q34410789-9919FBE4-8E97-486A-91FD-11CD91FCE578

P478

Q34410789-B6EF13DB-D498-4E32-810E-AC500AD84724

P50

Q34410789-5C7C4D89-C227-4C1E-AF51-F23B33C243E4

P577

Q34410789-1A4CB22B-3FBF-4A57-9D85-5D19A98BA458

P5875

Q34410789-0443B45C-F20B-4D7A-BBE1-DB4EE35B4405

P698

Q34410789-850B63FB-09CC-486C-9878-F72FF2BB0999

P932

Q34410789-5B7915FD-6FB4-42F5-9CB9-B91365B04DA2

P356

PNAS.0600287103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mucosal and systemic adjuvant activity of alphavirus replicon particles

@en

P2093

Alan C Whitmore

http://www.w3.org/2001/XMLSchema#string

Erin M B Richmond

http://www.w3.org/2001/XMLSchema#string

Jennifer L Konopka

http://www.w3.org/2001/XMLSchema#string

Joseph M Thompson

http://www.w3.org/2001/XMLSchema#string

Martha L Collier

http://www.w3.org/2001/XMLSchema#string

Nancy L Davis

http://www.w3.org/2001/XMLSchema#string

Robert E Johnston

http://www.w3.org/2001/XMLSchema#string

P2860

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Antiviral actions of interferons

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

The alphaviruses: gene expression, replication, and evolution

Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

Stimulation of local antibody production: parenteral or mucosal vaccination?

Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.

P304

3722-3727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0600287103

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7273028

http://www.w3.org/2001/XMLSchema#string

P698

16505353

http://www.w3.org/2001/XMLSchema#string

P932

1383499

http://www.w3.org/2001/XMLSchema#string